BOLD vs L · P/E 0.1, $24.6M cap vs P/E 14, rev $18.45B
Boundless Bio, Inc. Common Stock (BOLD) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
BOLD does not have a complete income-statement cache yet.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the BOLD and L stock pages for the full models.
Not investment advice.